Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate

@article{Pu2005DualsubtypeFV,
  title={Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate},
  author={R. Pu and J. Coleman and J. Coisman and E. Sato and T. Tanabe and M. Arai and J. Yamamoto},
  journal={Journal of Feline Medicine and Surgery},
  year={2005},
  volume={7},
  pages={65 - 70}
}
Vaccine trials were undertaken to determine whether the Fel-O-Vax® FIV, a commercial dual-subtype (subtypes A and D) feline immunodeficiency virus (FIV) vaccine, is effective against a subtype B FIV isolate. Current results demonstrate the Fel-O-Vax FIV to be effective against a subtype B virus, a subtype reported to be the most common in the USA. 
54 Citations
Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge
  • 13
Vaccine protection against feline immunodeficiency virus: setting the challenge.
  • 34
An updated nation-wide epidemiological survey of feline immunodeficiency virus (FIV) infection in Japan.
  • 22
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 20 REFERENCES
Vaccination of cats against feline immunodeficiency virus (FIV): a matter of challenge.
  • 16
  • Highly Influential
Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates
  • 66
Perspectives on FIV vaccine development.
  • 45
FIV vaccine development and its importance to veterinary and human medicine: a review
  • 100
Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.
  • 29
Vaccination with experimental feline immunodeficiency virus vaccines, based on autologous infected cells, elicits enhancement of homologous challenge infection.
  • 45
  • PDF
Enhancement after feline immunodeficiency virus vaccination.
  • 88
  • Highly Influential
MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.
  • 22
...
1
2
...